ZA934576B - 4-iminoquinolines processes for their preparation and their use - Google Patents

4-iminoquinolines processes for their preparation and their use

Info

Publication number
ZA934576B
ZA934576B ZA934576A ZA934576A ZA934576B ZA 934576 B ZA934576 B ZA 934576B ZA 934576 A ZA934576 A ZA 934576A ZA 934576 A ZA934576 A ZA 934576A ZA 934576 B ZA934576 B ZA 934576B
Authority
ZA
South Africa
Prior art keywords
iminoquinolines
processes
preparation
image
formula
Prior art date
Application number
ZA934576A
Other languages
English (en)
Inventor
Uta-Maria Billhardt-Troughton
Manfred Roesner
Rudolf Bender
Christoph Meichsner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA934576B publication Critical patent/ZA934576B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
ZA934576A 1992-06-27 1993-06-25 4-iminoquinolines processes for their preparation and their use ZA934576B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221210 1992-06-27

Publications (1)

Publication Number Publication Date
ZA934576B true ZA934576B (en) 1994-01-31

Family

ID=6462017

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934576A ZA934576B (en) 1992-06-27 1993-06-25 4-iminoquinolines processes for their preparation and their use

Country Status (19)

Country Link
US (1) US5602146A (enExample)
EP (1) EP0579968B1 (enExample)
JP (1) JP3605123B2 (enExample)
KR (1) KR940005577A (enExample)
CN (1) CN1083477A (enExample)
AT (1) ATE184003T1 (enExample)
AU (1) AU670435B2 (enExample)
CA (1) CA2099213C (enExample)
DE (1) DE59309756D1 (enExample)
DK (1) DK0579968T3 (enExample)
ES (1) ES2136628T3 (enExample)
GR (1) GR3031853T3 (enExample)
HU (1) HUT70040A (enExample)
IL (1) IL106147A (enExample)
MX (1) MX9303843A (enExample)
NZ (1) NZ247993A (enExample)
PH (1) PH31682A (enExample)
TW (1) TW304945B (enExample)
ZA (1) ZA934576B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344452A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4428932A1 (de) * 1994-08-16 1996-02-22 Hoechst Ag Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19613591A1 (de) * 1996-04-04 1997-10-09 Hoechst Ag Substituierte-Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
GB9930061D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Quinolone compounds for use in treating viral infections
AU2003301439A1 (en) * 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
SI1742642T1 (sl) * 2004-04-14 2009-04-30 Gilead Sciences Inc Fosfonatni analogi inhibitorskih spojin HIV integraze
EP2116527A4 (en) * 2007-01-23 2011-09-14 Fujifilm Corp OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, METHOD FOR MANUFACTURING THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT
JP5305704B2 (ja) * 2008-03-24 2013-10-02 富士フイルム株式会社 新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
JP6483382B2 (ja) * 2014-09-16 2019-03-13 株式会社Adeka 感光性樹脂組成物、その硬化物
JP6734416B2 (ja) * 2019-02-13 2020-08-05 株式会社Adeka 新規化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US758568A (en) * 1903-05-29 1904-04-26 William E Snediker Wrench.
GR79603B (enExample) * 1982-07-24 1984-10-31 Pfizer
ATE76293T1 (de) * 1985-11-21 1992-06-15 Anheuser Busch Glukosetoleranzfaktor und dessen herstellung.
US4985439A (en) * 1985-11-21 1991-01-15 Anheuser-Busch Companies, Inc. Glucose tolerance factor and method of making same
US5192768A (en) 1990-09-14 1993-03-09 Kyowa Hakko Kogyo Co., Ltd. Pyrazoloquinoline derivatives
ES2164639T3 (es) * 1991-04-15 2002-03-01 Aventis Pharma Gmbh Quinoxalinas, procedimiento para su preparacion y su empleo.

Also Published As

Publication number Publication date
AU4149293A (en) 1994-01-06
DK0579968T3 (da) 2000-03-27
CN1083477A (zh) 1994-03-09
JP3605123B2 (ja) 2004-12-22
US5602146A (en) 1997-02-11
EP0579968A1 (de) 1994-01-26
ES2136628T3 (es) 1999-12-01
CA2099213A1 (en) 1993-12-28
JPH0673012A (ja) 1994-03-15
AU670435B2 (en) 1996-07-18
IL106147A (en) 1997-06-10
NZ247993A (en) 1995-11-27
GR3031853T3 (en) 2000-02-29
ATE184003T1 (de) 1999-09-15
HUT70040A (en) 1995-09-28
EP0579968B1 (de) 1999-09-01
KR940005577A (ko) 1994-03-21
DE59309756D1 (de) 1999-10-07
PH31682A (en) 1999-01-18
IL106147A0 (en) 1993-10-20
TW304945B (enExample) 1997-05-11
HU9301875D0 (en) 1993-09-28
CA2099213C (en) 2005-11-29
MX9303843A (es) 1994-01-31

Similar Documents

Publication Publication Date Title
ZA937081B (en) Azaquinoxalines processes for their preparation and their use
ZA922722B (en) Quinoxalines,processes for their preparation,and their use
PH30118A (en) Phenylsulfonylamide pyrimidine
DE3468878D1 (en) 7-amino-azoloû1,5-a¨pyrimidines and fungicides containing them
EP0562049A4 (en) Novel 4-arylpiperazines and 4-arylpiperidines
IL99755A0 (en) Hydroxymethyl(methylenecyclopentyl)purines and pyrimidines and pharmaceutical compositions containing the same
GR3031853T3 (en) 4-Iminoquinolines, processes for their preparation and their use
MY132057A (en) Quinoxalinones, a process for their preparation and their use
ZA937859B (en) Antiretroviral acyl compounds
CA2051894A1 (en) Substituted 5-Alkoxy-1,2,4-Triazol-3-(Thi)Ones
IT1238549B (it) Apparecchiatura per l'alimentazione di prodotti.
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
ZA874596B (en) 3-substituted 1-(2-halogenoalkoxy-benzenesulphonyl)-3-heteroaryl-(thio)ureas
MY115291A (en) New substituted pyrazole derivatives, processes for their preparation nad their use as herbicides